SUMMARY Circulating immune complexes were found in 15 of 16 patients with fulminant hepatic failure due to viral hepatitis and all of six patients who had had halothane anaesthesia; however, they were found in only five of 32 patients with paracetamol-induced hepatic necrosis. The levels of circulating immune complexes were not related to the severity of the clinical course, development of renal failure, final outcome, or severity of hypocomplementaemia. All the patients had depressed reticuloendothelial function as assessed by the clearance of 1251 microaggregated albumin. These findings show that circulating immune complexes in fulminant hepatic failure are not simply a reflection of an immune response to liver antigens released as a result of the hepatic necrosis; nor are they a reflection of the failure of the reticuloendothelial system. This supports the view that circulating immune complexes are associated with immune mediated liver injury and may contribute to the process.
The mechanism responsible for the progression of some cases of acute viral hepatitis to fulminant hepatic failure is poorly understood. In Functional activities of total haemolytic complement (CH,o) and total alternative pathway were measured in 20 patients by haemolytic diffusion in agarose.
Concentrations of immunoreactive C3 were determined by radial immunodiffusion against rabbit antiserum (kindly provided by Professor D K Peters). Results were expressed as a percentage of the activity of a control serum pool, derived from six healthy laboratory personnel, which was included as a standard in each plate.
ASSESSMENT OF RETICUI OENDOTHELIAL SYSTEM FUNCTION
Microaggregated iodinated serum albumin ('25IMAA) was prepared by the method of lio and Wagner5 as previously reported. 14 After an intravenous injection of sodium iodide to block radio-iodine uptake by the thyroid, '25IMAA, 5 mg/kg body weight was injected; 2 ml blood samples were taken into EDTA anticoagulant 0, 3, 5, 7, 10, 12, 15, and 20 minutes later. The plasma was separated immediately and the ' 2I activity in a 0.5 ml aliquot was counted with a gamma counter (Hewlett Packard). The half life (t'/2) of clearance was calculated by plotting log,o counts per minute against time in minutes. Four normal volunteers acted as controls.
Results
Fifteen of the 16 patients with fulminant hepatic failure attributed to viral hepatitis had raised levels of circulating immune complexes, with a mean for the 16 patients of 33.6 ± SD 14.3%, which was significantly (P <001, Wilcoxon's rank sum test) higher than the mean of 9.6± 3 for controls (Figure) . The raised level of circulating immune complexes in patients with viral hepatitis was not related to the type of viral hepatitis, to the severity of the clinical course, or final outcome. The six patients with halothane-associated hepatitis also had higher levels of circulating immune complexes than controls, with a mean of 31-4±SD 14.5, which was similar to that in patients with viral hepatitis (Figure) . In contrast, 27 of the 32 patients with paracetamol overdose had normal levels, with a mean for the 32 patients of 13-5 ± SD 3 4. Five patients had raised levels; the two with the highest values had received transfusions of plasma protein fraction within the preceding 12 hours, and one of these two patients also had an E. coli septicaemia. Similarly, the patient with the highest levels of immune complexes in the halothane-associated hepatitis group had pneumonia. Except for these three patients, no other patients in the series had evidence of bacterial infection or had received blood products before the first sample was taken. Serial studies of circulating immune complexes showed that, in patients with viral and halothane-associated hepatitis, levels remained raised. Similarly, in patients with paracetamol overdose, levels remained within the normal range unless complicated by the development of cultureproven bacterial infection or administration of blood products, which.in three patients was associated with a mean increase of 220% of initial levels.
Nine patients had renal failure (creatinine >350 plmol/l or urine output <300 ml/24 h) during the study, and in 14 others it developed later. There was no difference in levels of circulating immune complexes between patients who did or did not develop renal failure, or in whom it had already developed.
SERUM COMPl EMENT AND RETICULOENDOTHEI IAL FUNCTION
The functional activity of the alternative and classical pathways (CHso) of complement and levels of immunoreactive C3 were reduced in all 20 patients :W:# h::
::
studied to a mean of less than 30% of the activity ofthe control serum pool (Table) . The severity of the complement deficiency was similar in patients with viral hepatitis, halothane-associated hepatitis, and paracetamol overdose and there was no correlation between the level of serum complement and that of circulating immune complexes. The plasma half-life (t /2) of 2IMAA was prolonged in all 25 patients studied, ranging from 18 to 36 minutes compared with an upper limit of normal for controls of 15-6 (mean + 2 SD). There was no difference in the degree of prolongation of t'/2 between any of the patient froups; and no correlation was found between the t /2 and either levels of circulating immune complexes or complement levels. Zubler et al. (1976) " only heparin is a potential problem and, as each of our patient groups received similar amounts, this is unlikely to be a source of significant error. As sera from all the patient groups were handled in the same way with respect to collection, separation, and storage, variations of aggregation of immunoglobulin or formation of cryoprecipitates are unlikely to account for the difference in Clq binding activity between the different patient groups.
The severe impairment of the function of the reticuloendothelial system shown by the prolonged clearance from the circulation of '25IMAA in all the patients with fulminant hepatic failure, irrespective of aetiology, has several important implications. Such a defect would impair the clearance from the circulation of circulating immune complexes, bacteria, and endotoxins, which has been shown in animal studies to contribute to liver damage."' Both parenchymal and non-parenchymal liver cells are thought to be the site of synthesis of many complement factors, and with massive liver cell necrosis the production of these will be reduced. This almost certainly explains the low levels of complement found in all patients studied, including those in whom circulating immune complexes were not increased. As complement turnover studies cannot be performed in vivo, because of the short duration of illness and unstable clinical course, the importance of complement consumption cannot be assessed. Serum complement deficiency may contribute to the increased levels of circulating immune complexes, as there is evidence that the alternative pathway of complement is involved in the solubilisation of immune complexes. '8 Renal failure has been attributed to immune complex deposition in some cases of acute viral hepatitis, especially type B, but in our patients there was no correlation between levels of circulating immune complexes and the occurrence of renal failure. Furthermore, renal failure occurred with equal frequency in cases of fulminant hepatic failure attributed to both paracetamol overdose or viral hepatitis, although levels of circulating immune complexes were normal in the former. It is more likely that the impairment of the reticuloendothelial system predisposes to the development of systemic endotoxaemia with consequent renal vasoconstriction and renal failure.'9
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